Sridhar Narayan

Sridhar Narayan has a range of work experience in the pharmaceutical and biotech industries. Sridhar is currently working as the Vice President at ReviR Therapeutics starting in October 2022. Prior to this, they worked at Yale University as an Entrepreneur In Residence starting in 2019. Before that, they held various roles at Satellos Bioscience Inc., including Vice President of Drug Discovery and Program Leadership from an unknown start date to October 2022, and Head of Drug Discovery and Development from an unknown start date to 2021. Sridhar has also worked as a Drug Discovery and Development Consultant in the biotech, pharma, and venture capital sectors from an unknown start date to October 2022. Additionally, they have served as the Project Director and a member of the Scientific Advisory Board at Appili Therapeutics from an unknown start date to 2020. Sridhar has also worked as the Director of Medicinal Chemistry at Navitor Pharmaceuticals from an unknown start date to 2017. Prior to that, Sridhar worked as a Principal Scientist and Team Leader at AstraZeneca from an unknown start date to 2015. Sridhar has also held positions at Eisai as a Senior Scientist from 2009 to 2012, and as a Research Investigator from 2006 to 2009. Sridhar's early career includes working as a Skaggs Postdoctoral Fellow at The Scripps Research Institute from 2003 to 2006, where they conducted research on the "On Water" Effect and Ru-catalyzed click reaction under the supervision of Prof. K. Barry Sharpless.

Sridhar Narayan completed their education with a Bachelor of Science (B.Sc.) degree in Chemistry from the University of Mumbai between 1992 and 1995. Sridhar pursued further studies in Organic Chemistry and earned a Master of Science (M.Sc.) degree from the Indian Institute of Technology, Bombay, from 1995 to 1997. Afterward, they enrolled at the University of Michigan and obtained a Ph.D. in Organic Chemistry, studying from 1997 to 2003. In recent years, Sridhar Narayan pursued a Master of Business Administration (MBA) degree with a specialization in Health/Health Care Administration/Management at the Yale School of Management, completing their studies between 2018 and 2020.